Readers like you keep news free for everyone.

More than 5,000 readers have already pitched in to keep free access to The Journal.

For the price of one cup of coffee each week you can help keep paywalls away.

Not now

# cost effective

All time

Two-tier drug access a 'real issue' for equity says head of HSE's drug-review centre

VHI recently offered its members access to new cancer drugs not currently available to all HSE patients.

10.2k

Apr 15th 2019, 4:35 PM

'The system is not adequate': Government sets up new way to judge medicines for rare diseases

Many drugs for rare diseases have been ruled as not “cost-effective” under existing criteria.

9.6k

Nov 15th 2017, 10:05 PM